Last reviewed · How we verify
NCT05100459: WheyProtein
The Effects of Whey Protein Supplements on Markers of Exercise-induced Muscle Damage in Resistance-trained Individuals
NA trial testing Pasture-raised whey protein in Muscle Damage in 39 participants. Completed in 14 June 2022.
14 June 2022
Quick facts
| Lead sponsor | Indiana University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | basic science |
| Enrollment | 39 |
| Start date | 15 November 2021 |
| Primary completion | 14 June 2022 |
| Estimated completion | 14 June 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Pasture-raised whey protein
- Conventional whey protein
- Placebo
Conditions studied
- Muscle Damage — all drugs for Muscle Damage →
- Muscle Soreness — all drugs for Muscle Soreness →
Sponsor
Indiana University
Who can join
Adults 18 to 40, any sex, with Muscle Damage or Muscle Soreness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Intense exercise can bring about various side effects to one's body. Less range of motion, increased pain sensitivity, increased muscle swelling, and decreased muscle strength can occur immediately after exercise. These side effects can be referred to exercise induced muscle damage (EIMD) and can sometimes last many days. This study's goal is to evaluate the effects of various protein supplements on EIMD symptoms as well as on blood vessel health during the recovery period after muscle damaging exercise.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05100459
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Muscle Damage
Currently open trials in the same condition.
- NCT06837298 — The Effect of Vicia Faba Hydrolysate Supplementation on Muscle Strength Recovery · NA · recruiting
- NCT06432868 — Solarplast (R) Supplementation Effects Following High-intensity Resistance Exercise · NA · recruiting
- NCT06992271 — Comparing Two Eccentric Protocols on Muscle Damage · NA · recruiting
- NCT04900506 — Surgical Approach in Hemiarthroplasty. A Randomized Clinical Trial Comparing Posterior and Anterior Approach · NA · active not recruiting
- NCT04549610 — HMB and Exercise-induced Muscle Damage · Phase 2, PHASE3 · recruiting
Other Indiana University trials
Trials by the same sponsor.
- NCT07470086 — The Role of Environmental Temperatures in Respiratory Control · NA · not yet recruiting
- NCT07470099 — The Role of Breathing Perception in Respiratory Control · NA · not yet recruiting
- NCT07179952 — Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA ) · Phase 2 · not yet recruiting
- NCT07070804 — Maternal Biomarkers and Environmental Contributors to Autism Spectrum Disorders in Children of First-time Mothers · not yet recruiting
- NCT07499583 — Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05100459 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Indiana University
- Last refreshed: 2 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05100459.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing